China permits Indian students to return on 'need-assessed' basis
Darpan News Desk IANS, 29 Apr, 2022 12:10 PM
New Delhi, April 29 (IANS) China has allowed return of Indian students to its various universities on a "need-assessed basis", according to the Indian Embassy in China.
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.
In order to facilitate this, the Indian Embassy intends to prepare a list of such students which will be shared with the Chinese side for their consideration.
The embassy has come up with a form and requested Indian students to fill out citing their necessity.
Once the collated information is shared with the Chinese side, it would consult relevant Chinese departments and varsities to verify the list and indicate whether the identified students can travel to China to complete the course.
This coordination process would be carried out in a time-bound manner.
The Chinese side has also conveyed that eligible students should unconditionally abide by Covid-19 prevention measures, and agree to bear all expenses related to Covid-19 prevention measures by themselves.
Over 23,000 Indian students, primarily studying medicines, are stuck back home due to Covid-19 visas and flight bans by China in attempt to control spread of Covid-19.
If elected, Biden said, he would impose stiff new tax penalties on companies that manufacture U.S.-bound products outside the country, create incentives for keeping jobs on U.S. soil and close what he called "Trump loopholes" that allow companies engaged in offshoring to avoid paying U.S. taxes.
A spokesperson for AstraZeneca, via a statement said that the company’s “standard review process triggered a pause to vaccination to allow review of safety data.”
Prosecutors, defence lawyers and District Judge Theodore Chuang gathered today via conference call to set deadlines for the government's response to the motions and to set a hearing date.
Thursday’s report comes nearly two years after a Chinese scientist shocked the world by revealing he’d helped make the first gene-edited babies using a tool called CRISPR, which enables DNA changes or “edits” that can pass to future generations.
In an online forum today hosted by the Washington International Trade Association, DeFrancesco squared off against critics of the decision, including leading industry groups in both Canada and the U.S.
.jpg "AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject")
